(Q41334602)

29 September 2017

1 reference

title

Tuberculosis in Africa: clinical presentation and management (English)

1 reference

29 September 2017

0 references

Harries AD

1

1 reference

PubMed ID

9014205

29 September 2017

language of work or name

1 reference

1 January 1997

1 reference

Pharmacology & Therapeutics

29 September 2017

1 reference

29 September 2017

73

1 reference

29 September 2017

1

1 reference

29 September 2017

1-50

1 reference

Quality control in tuberculosis bacteriology. 1. Laboratory studies on isolated positive cultures and the efficiency of direct smear examination

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pneumocystis cariniiPneumonia: An Uncommon Cause of Death in African Patients with Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Radiologic manifestations of pulmonary tuberculosis in HIV-1 and HIV-2-infected patients in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Interaction of rifampicin with other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic Methods

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Corticosteroids and tuberculosis: risks and use as adjunct therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis and chemoprophylaxis in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pneumocystis carinii pneumonia and tuberculosis in Tanzanian patients infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Chest roentgenogram in pulmonary tuberculosis. New data on an old test

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pulmonary tuberculosis in Kigali, Rwanda. Impact of human immunodeficiency virus infection on clinical and radiographic presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pleural effusion, tuberculosis and HIV-1 infection in Kigali, Rwanda.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Directly observed therapy for tuberculosis: history of an idea

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The value of wide-needle aspiration in the diagnosis of tuberculous lymphadenitis in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculous meningitis in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Malabsorption of antituberculosis medications by a patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The global epidemiology of HIV infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Streptomycin plus thiacetazone (thioacetazone) compared with streptomycin plus PAS and with isoniazid plus thiacetazone in the treatment of pulmonary tuberculosis in Rhodesia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Aspects of tuberculosis in Africa. 2. The value of microbiology in the management of tuberculosis in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Infection and morbidity in patients with tuberculosis in Nairobi, Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

AIDS and the lung: update 1995. 3. Intrathoracic Kaposi's sarcoma in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Drug resistant tuberculosis in sub-Saharan Africa: an estimation of incidence and cost for the year 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculous pericarditis in Tanzanian patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The supply of antituberculosis drugs and national drugs policies.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The supply of antituberculosis drugs: price evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Seroprevalence of human immunodeficiency virus type 1 infection in Zambian children with tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Impact of the change from an injectable to a fully oral regimen on patient adherence to ambulatory tuberculosis treatment in Dar es Salaam, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

HIV infection in patients with tuberculosis in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Identification of an effective vaccine against tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Field trials of tuberculosis vaccines: how could we have done them better?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The diagnosis of pulmonary tuberculosis in malnourished Kenyan children.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis recurrence in Africa: true relapse or re-infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The typically 'atypical' radiographic presentation of tuberculosis in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis control in resource-poor countries: alternative approaches in the era of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis and HIV infection in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis in prisons--forgotten plague

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Antituberculous therapy and acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa. Third Report of Fifth Investigation. A co-operative study in East Africian hospitals, clinics and laboratories with the collaboration of the East

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis in Tanzania: a follow-up of a national sampling survey of drug resistance and other factors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

A study of the use of maternity and child welfare clinics in case-finding for pulmonary tuberculosis in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Thiacetazone: time to call a halt? Considerations on the use of thiacetazone in African populations with a high prevalence of human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Impact of HIV on tuberculosis in Zambia: a cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis and immunodeficiency in HIV-1-infected patients in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Treatment of tuberculosis in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pneumocystis carinii is not a major cause of pneumonia in HIV infected patients in Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Interaction of Ketoconazole with Rifampin and Isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Screening for active tuberculosis in HIV testing centre

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Value of Repeat Lumbar Puncture in the Differential Diagnosis of Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Management of acquired bullous skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Variation in protection by BCG: implications of and for heterologous immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The impact of human immunodeficiency virus infection on tuberculosis and its control

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Patterns of tuberculin hypersensitivity in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Compliance of patients and physicians: experience and lessons from tuberculosis-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis case-finding and treatment programmes in the developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The emergence of drug-resistant tuberculosis in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Improved microscopical diagnosis of pulmonary tuberculosis in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Drug-resistant tuberculosis in Sierra Leone

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The clinical challenge of the HIV epidemic in the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from patients with pulmonary tuberculosis in northern Tanzania.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Patterns of initial and acquired antituberculosis drug resistance in Karonga District, Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

A comparison of clinical features in tuberculosis associated with infection with human immunodeficiency viruses 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Recurrence of HIV-related tuberculosis in an endemic area may be due to relapse or reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Recruitment to a trial of tuberculosis preventive therapy from a voluntary HIV testing centre in Lusaka: relevance to implementation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

AIDS in Uganda--clinical and social features

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis control. Back to the future?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Immunotherapy of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Treatment of tuberculosis in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

A prospective study of the risk of tuberculosis among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis and human immunodeficiency virus infection in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

An audit of HIV testing and HIV serostatus in tuberculosis patients, Blantyre, Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Sputum smears for diagnosis of smear-positive pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis programme changes and treatment outcomes in patients with smear-positive pulmonary tuberculosis in Blantyre, Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Perinatal transmission of HIV-I in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

A Controlled Trial of 3-Month, 4-Month, and 6-Month Regimens of Chemotherapy for Sputum-smear-negative Pulmonary Tuberculosis: Results at 5 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Towards the elimination of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The association of tuberculosis and HIV infection in Harare, Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Factors of prognostic significance in Chinese children with tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Adverse cutaneous reactions to thiacetazone for tuberculosis treatment in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Treatment of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Fatal BCG infection in an immunocompetent girl

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

HIV seropositivity and tuberculosis in a rural Malawi hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Cutaneous reactions to thiacetazone in Zambia--implications for tuberculosis treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis in Kenya 1984: a third national survey and a comparison with earlier surveys in 1964 and 1974. A Kenyan/British Medical Research Council Co-operative Investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The global tuberculosis situation and the new control strategy of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Case holding in patients with tuberculosis in Botswana

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Drug-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Nosocomial transmission of HIV in Africa: what tribute is paid to contaminated blood transfusions and medical injections?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Harnessing the strengths of the leprosy programme to control tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The mortality and pathology of HIV infection in a west African city.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Contribution of tuberculosis to slim disease in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Disease in children infected with HIV in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Human immunodeficiency virus type-1 infection in Zambian children with tuberculosis: changing seroprevalence and evaluation of a thioacetazone-free regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pneumocystis carinii pneumonia in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Symptoms and investigative findings in 145 patients with tuberculous peritonitis diagnosed by peritoneoscopy and biopsy over a five year period

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Corticosteroids in treatment of disseminated tuberculosis in patient with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Prevalence of HIV infection among patients with leprosy and tuberculosis in rural Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis among health care workers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis and HIV infection association in a rural district of northern Uganda: epidemiological and clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

An international co-operative investigation into thiacetazone (thioacetazone) side-effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The action of antituberculosis drugs in short-course chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Radiographic abnormalities in tuberculosis and risk of coexisting human immunodeficiency virus infection. Methods and preliminary results from Bujumbura, Burundi

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Radiographic abnormalities in tuberculosis and risk of coexisting human immunodeficiency virus infection. Results from Dar-es-Salaam, Tanzania, and scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Two-year HIV-1-associated mortality in a Ugandan rural population

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculous lymphadenitis associated with human immunodeficiency virus (HIV) in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

A clinical and pathological comparison of the WHO and CDC case definitions for AIDS in Kinshasa, Zaïre: is passive surveillance valid?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Primary and secondary resistance of mycobacterium tuberculosis in Eastern Botswana

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Surveillance of resistance to antituberculosis drugs in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Cross-sectional survey of HIV infection among patients with tuberculosis in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The impact of HIV on resource utilization by patients with tuberculosis in a tertiary referral hospital, Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Thiacetazone--avoid like poison or use with care?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The challenge of diagnosing childhood tuberculosis in a developing country

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pulmonary tuberculosis in HIV-infected patients with normal chest radiographs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Malabsorption of antimycobacterial medications

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Should pulmonary tuberculosis be an AIDS-defining diagnosis in patients infected with HIV?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis control and the AIDS epidemic in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis, Atypical Mycobacteriosis, and the Acquired Immunodeficiency Syndrome Among Haitian and Non-Haitian Patients in South Florida

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Fine-needle extrathoracic lymph-node aspiration in HIV-associated sputum-negative tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculous pericardial effusion associated with HIV infection: a sign of disseminated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

HIV infection in patients admitted to a general hospital in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Clinical Characteristics of Tuberculous Lymphadenitis in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis in HIV positive patients in South Africa: a comparative radiological study with HIV negative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis and HIV infection in children in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

AIDS, tuberculosis, and the health care worker

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in an area endemic for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Predictors of survival in HIV-infected tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Ten-year results during the introduction of chemotherapy for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The association of tuberculosis and HIV infection in Burundi

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

1 reference

7 January 2021

Rapid resolution of tuberculous pericardial effusions with high dose prednisone and anti-tuberculous drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis and HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculous meningitis due to BCG in two previously healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Multidrug-resistant tuberculosis in patients without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Bed occupancy due to HIV/AIDS in an urban hospital medical ward in Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Human immunodeficiency virus infection in tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Transmission of tuberculosis to contacts of sputum positive adults in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

High initial drug resistance in pulmonary tuberculosis in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Patient compliance with tuberculosis treatment in Ghana: factors influencing adherence to therapy in a rural service programme

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Tuberculosis or persistent generalised lymphadenopathy in HIV disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Diagnostic value of ascites adenosine deaminase in tuberculous peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

High-compliance tuberculosis treatment programme in a rural community

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900115-5

7 January 2021

10.1016/S0163-7258(96)00115-5

Identifiers

DOI

1 reference

29 September 2017

1 reference

PubMed ID

9014205